Startups

Capacity Bio logo

Capacity Bio

Develops medicines that restore mitochondrial quality by inducing mitophagy, the process that removes and replaces damaged mitochondria. Its research includes small molecules, peptides and nanoparticles designed to activate clearance pathways and address mitochondrial dysfunction associated with disease and aging.

Team

Aaron BergenerChief Financial Officer
Aiden AcevesBoard Observer
Amy WangChief Operating Officer and Board Member
Dylan MorrisBoard Member
Gere diZeregaExecutive Medical Director
Joji HayashidaVP of Administration, Japan
Kaitlin MackayController
Kathleen RodgersChief Medical Officer
Ken HorneChief Executive Officer and Board Member
Kevin GaffneyChief Scientific Officer
Masanobu UchidaChief Development Officer, Japan
Noriko KanaiChief Financial Officer, Japan
Orian ShirihaiScientific Advisor
Rebecca SilbermanBoard Observer
Takashi FutamiManaging Member, Japan
Taro InabaBoard Member

Investments

$—Unknown dateAN Venture Partners